Cohort studyindependent cross-checkabstract checked★ key study I-CAN-123 in-depth review

Cancer in Hiroshima and Nagasaki survivors

Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009.

Overview

Grant EJ et al.. Radiat Res 2017 · PMID 28319463 · DOI 10.1667/RR14492.1

Radiation raised solid cancer risk even at doses of 0-100 mGy; most cancers in survivors were due to other causes.

Does the study support the specific claim? No · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Radiation dose and cancer.

How was the study done?

Cohort, 1958-2009.

How many people, animals or samples were studied?

105,444 people.

What was actually found?

Dose-related increase, also at low doses.

How large was the observed effect?

ERR 0.64/Gy (women).

What do the results mean in everyday life?

Not only massive exposures matter.

What are the study's limitations?

Low-dose shape uncertain.

What does it say about Elawady's specific claim?

Contradicts 'only Hiroshima-like exposures'.

Do the results apply to Germany and Europe?

High.

What can explicitly not be concluded from this study?

Smoking effects (adjusted, not studied).

Scientific in-depth review

1. Full reference

Authors
Grant EJ et al.
Journal
Radiat Res
Year
2017
Identifier
PMID 28319463 DOI 10.1667/RR14492.1
Verification
verified – PubMed efetch 2026-10-26 + Crossref
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

NIH and other grants (PubMed)

2. Research question

Solid cancer incidence in relation to radiation dose, adjusted for smoking

3. Study design and population

Study design
Cohort study – Prospective cohort (Life Span Study of atomic bomb survivors)
Population

Atomic bomb survivors and unexposed residents of Hiroshima and Nagasaki

Country

Japan

Period

Follow-up 1958-2009

Sample size

105,444 subjects; 22,538 incident first primary solid cancers

Inclusion and exclusion criteria

Alive and cancer-free at start of follow-up

4. Methods and endpoints

Exposure / intervention

Weighted absorbed colon dose

Comparator

Lower/zero dose

Endpoints

Solid cancer incidence

Statistical methods

Poisson regression; ERR and EAR models adjusted for smoking

5. Actual results

Results

992 of 22,538 solid cancers associated with radiation exposure. Female ERR 0.64 per Gy (0.52-0.77); male linear-quadratic ERR 0.20 at 1 Gy; lowest dose range with significant sex-averaged linear dose response 0-100 mGy (P=0.038). Risks remain elevated >60 years after exposure.

Absolute risks

992 radiation-associated cases (4.4% of solid cancers)

Authors' conclusion

Solid cancer risks remain elevated >60 years after exposure; dose-response shape uncertain.

6. Strengths

  • Large, long follow-up
  • Individual dose estimates
  • Smoking adjustment

7. Weaknesses

  • Dose-response shape uncertain at low doses

8. Risk of bias

Orienting tool
ROBINS-E
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
low
Rationale

High-quality cohort.

9. Assessment of the statistical interpretation

Radiation-associated share recalculated as 4.4%.

10. Relevance to the specific claim

Confirms Elawady's point that massive radiation causes cancer, but shows a dose response down to 0-100 mGy and that most cancers in survivors had other causes, including smoking (adjusted for).

11. Independent contrary findings

Supports the correct part of the claim (high-dose radiation causes cancer).

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Refutes 'only massive exposures cause cancer'.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biaslow
Precision of resultshigh
Directnessindirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Exact low-dose shape.

15. Linked fact checks